Evelo Biosciences, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
OTC.Pink
Evelo Biosciences' stockholders have approved the company's plan for liquidation and dissolution at a special meeting held on January 26, 2024.